» Articles » PMID: 35356091

Recent Advance in Treatment of Atherosclerosis: Key Targets and Plaque-positioned Delivery Strategies

Overview
Journal J Tissue Eng
Date 2022 Mar 31
PMID 35356091
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis, a chronic inflammatory disease of vascular wall, is a progressive pathophysiological process with lipids oxidation/depositing initiation and innate/adaptive immune responses. The coordination of multi systems covering oxidative stress, dysfunctional endothelium, diseased lipid uptake, cell apoptosis, thrombotic and pro-inflammatory responding as well as switched SMCs contributes to plaque growth. In this circumstance, inevitably, targeting these processes is considered to be effective for treating atherosclerosis. Arriving, retention and working of payload candidates mediated by targets in lesion direct ultimate therapeutic outcomes. Accumulating a series of scientific studies and clinical practice in the past decades, lesion homing delivery strategies including stent/balloon/nanoparticle-based transportation worked as the potent promotor to ensure a therapeutic effect. The objective of this review is to achieve a very brief summary about the effective therapeutic methods cooperating specifical targets and positioning-delivery strategies in atherosclerosis for better outcomes.

Citing Articles

Prophylactic and therapeutic effects of EsV3 on atherosclerotic lesions in ApoE mice.

Wang Y, Ohishi H, Wu R, Liu H, Xu R BMC Cardiovasc Disord. 2025; 25(1):54.

PMID: 39865227 PMC: 11770915. DOI: 10.1186/s12872-025-04497-y.


Garlic ameliorates atherosclerosis by regulating ferroptosis pathway: an integrated strategy of network pharmacology, bioinformatic and experimental verification.

Gao T, Gao S, Wang H, Wang S, Li L, Hu J Front Pharmacol. 2024; 15:1388540.

PMID: 39108744 PMC: 11300214. DOI: 10.3389/fphar.2024.1388540.


Lecithin and cardiovascular health: a comprehensive review.

Onaolapo M, Alabi O, Akano O, Olateju B, Okeleji L, Adeyemi W Egypt Heart J. 2024; 76(1):92.

PMID: 39001966 PMC: 11246377. DOI: 10.1186/s43044-024-00523-0.


Investigating the therapeutic effects and mechanisms of Carthamus tinctorius L.-derived nanovesicles in atherosclerosis treatment.

Yang R, Lin F, Wang W, Dai G, Ke X, Wu G Cell Commun Signal. 2024; 22(1):178.

PMID: 38475787 PMC: 10936069. DOI: 10.1186/s12964-024-01561-6.


Research progress of absorbable stents.

Song Y, Li B, Chen H, Yu Z Int J Med Sci. 2024; 21(2):404-412.

PMID: 38169581 PMC: 10758145. DOI: 10.7150/ijms.90012.


References
1.
Bashth O, Elkhodiry M, Laroche G, Hoesli C . Surface grafting of Fc-binding peptides as a simple platform to immobilize and identify antibodies that selectively capture circulating endothelial progenitor cells. Biomater Sci. 2020; 8(19):5465-5475. DOI: 10.1039/d0bm00650e. View

2.
Fujiu K, Manabe I, Ishihara A, Oishi Y, Iwata H, Nishimura G . Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5. Circ Res. 2005; 97(11):1132-41. DOI: 10.1161/01.RES.0000190613.22565.13. View

3.
He L, Weng H, Li Q, Shi G, Liu X, Du Y . Lactucopicrin Inhibits Cytoplasmic Dynein-Mediated NF-κB Activation in Inflammated Macrophages and Alleviates Atherogenesis in Apolipoprotein E-Deficient Mice. Mol Nutr Food Res. 2020; 65(4):e2000989. DOI: 10.1002/mnfr.202000989. View

4.
Zhaolin Z, Guohua L, Shiyuan W, Zuo W . Role of pyroptosis in cardiovascular disease. Cell Prolif. 2018; 52(2):e12563. PMC: 6496801. DOI: 10.1111/cpr.12563. View

5.
Song H, Wu T, Yang X, Li Y, Ye Y, Li B . Surface Modification with NGF-Loaded Chitosan/Heparin Nanoparticles for Improving Biocompatibility of Cardiovascular Stent. Stem Cells Int. 2021; 2021:9941143. PMC: 8093045. DOI: 10.1155/2021/9941143. View